Single - Dose PCV13 Immunogenic, Safe in Pediatric Oncology

After vaccination, ≥ 70 percent had protective antibody titers for S. pneumoniae serotypes
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Infections, Oncology, Pediatrics, Pharmacy, Journal, Source Type: news